[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.48.3. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
JAMA Patient Page
January 28, 2009

Acute Lymphoblastic Leukemia

JAMA. 2009;301(4):452. doi:10.1001/jama.301.4.452

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and represents about one-quarter of all cancers among persons younger than 15 years. Acute lymphoblastic leukemia is a cancer of the blood and bone marrow (spongy tissue in the center of bone). In ALL, too many bone marrow stem cells develop into a type of white blood cell called lymphocytes. These abnormal lymphocytes are not able to fight infection very well. Also, as the number of these lymphocytes increases, there is less room for healthy white blood cells, red blood cells, and platelets. This may lead to infection, fatigue, and easy bleeding. The January 28, 2009, issue of JAMA includes an article about genetic variations associated with treatment response in childhood ALL. This Patient Page is based on one previously published in the March 21, 2007, issue of JAMA.

LEUKEMIA SYMPTOMS

  • Fatigue

  • Fever

  • Easy bruising

  • Bone pain

DIAGNOSTIC TESTS

  • Complete blood count (CBC)—a blood test that checks the number of red blood cells, white blood cells, and platelets.

  • Bone marrow aspiration—a needle is placed into the hip bone or breastbone and a sample of bone marrow is taken and examined for signs of cancer.

  • Cytogenetic analysis—lymphocytic cells taken from blood or bone marrow are examined to see if there are any changes in their chromosomes (genetic material).

  • Immunophenotyping—a test to see if cancer lymphocytes originated from B lymphocytes or T lymphocytes. This information is helpful in treating ALL.

PROGNOSIS AND TREATMENT

Prognosis (chance of recovery) from childhood ALL is usually very good; however, both prognosis and treatment depend on

  • Age and white blood cell count at diagnosis

  • Response to initial treatment

  • Origin of leukemia cells (from B or T lymphocytes)

  • Certain changes in the chromosomes of the lymphocytes

  • Involvement of the brain and spinal cord

Different types of treatment programs are available. Some programs are standard (currently used) and some are being tested in clinical trials (experimental). Most use chemotherapy (drug therapy). In addition, some patients may also need radiation therapy (use of high-energy x-rays) or bone marrow transplantation.

FOR MORE INFORMATION

INFORM YOURSELF

To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A previous Patient Page on childhood leukemia was published in the January 28, 2004, issue.

Sources: American Cancer Society, American Academy of Pediatrics
Photo credit: Mihaela Onciu, MD/St Jude Children's Research Hospital

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.

TOPIC: CHILDHOOD ILLNESSES

×